- Tytuł:
- Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology December 2019 20(12):1750-1759
Czasopismo naukowe